Stay updated with breaking news from Biodesix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street brokerages expect Biodesix, Inc. (NASDAQ:BDSX – Get Rating) to announce earnings of ($0.36) per share for the current quarter, Zacks reports. Three analysts have made estimates for Biodesix’s earnings. The highest EPS estimate is ($0.24) and the lowest is ($0.47). Biodesix reported earnings of ($0.41) per share during the same quarter last year, […]
11.05.2022 - Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for first quarter ended March 31, 2022 and provided a corporate update. “We are ...
Equities research analysts predict that Biodesix, Inc. (NASDAQ:BDSX – Get Rating) will post $6.88 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Biodesix’s earnings, with estimates ranging from $6.60 million to $7.15 million. Biodesix reported sales of $28.87 million during the same quarter last year, which […]
Equities analysts expect Biodesix, Inc. (NASDAQ:BDSX – Get Rating) to post ($0.38) earnings per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Biodesix’s earnings, with the highest EPS estimate coming in at ($0.35) and the lowest estimate coming in at ($0.41). Biodesix reported earnings of ($0.23) per […]
Equities research analysts expect Biodesix, Inc. (NASDAQ:BDSX – Get Rating) to report earnings per share (EPS) of ($0.38) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Biodesix’s earnings. The lowest EPS estimate is ($0.41) and the highest is ($0.35). Biodesix posted earnings of ($0.23) per share during the same […]